Sean Edwards

Sean Edwards has an extensive work experience spanning several companies and roles. Currently, they serve as the Chief Executive Officer of Regencor Inc., a regenerative medicine company focusing on heart disease. Sean is responsible for driving the company's mission to reduce morbidity and mortality from myocardial infarction and prevent the progression to heart failure. Prior to this, Sean was a Board Member at Contract Pharmaceuticals Limited and served as the President of GRI Bio, Inc. Sean has also been a Member of YPO since 2011. Notably, Sean held the positions of Executive Chairman & Board Member and Interim Chief Executive Officer at NeuraLace Medical, Inc., a company working on non-invasive medical devices for chronic pain treatment. Sean has also served as the President of EvoMed (Holding) LLC and Cosmederm Bioscience, where they held the positions of President/CEO and VP of Business Development and General Counsel. Previously, Sean worked as the Director of Business Development at Innovaro.

Sean Edwards attended Princeton University from 1988 to 1992, where they obtained an A.B. degree in History with a concentration in American History. Sean then pursued further education at the University of San Diego School of Law from 1994 to 1996 and earned a Doctor of Law (JD) degree.